Prime Medicine, Inc. (PRME) Operating margin 2020–2025
Prime Medicine, Inc. (PRME) operating margin by fiscal year — reported operating income divided by reported revenue.
-4498.1%FY2025 · since FY2020: -17.9% → -4498.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4498.1% | +2289.3 pp |
| FY2024 | -6787.4% | — |
| FY2020 | -17.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PRME financial trends
PRME RevenuePRME Net incomePRME Net marginPRME Gross profitPRME Gross marginPRME Operating incomePRME Operating cash flowPRME Free cash flowPRME Capital expendituresPRME Return on equityPRME Stock buybacksPRME Dividends paidPRME Total assetsPRME Total liabilitiesPRME Shareholders’ equityPRME overview →